D36.10 is a billable ICD-10 code used to specify a medical diagnosis of benign neoplasm of peripheral nerves and autonomic nervous system, unspecified. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic ganglia [See Also: Neoplasm, nerve, peripheral] ; Neoplasm, neoplastic nerve (ganglion) ; Neoplasm, neoplastic nerve (ganglion) autonomic NEC [See Also: Neoplasm, nerve, peripheral] ; Neoplasm, neoplastic nerve (ganglion) ganglion NEC [See Also: Neoplasm, nerve, peripheral] ; Neoplasm, neoplastic nerve (ganglion) parasympathetic NEC ; Neoplasm, neoplastic nerve (ganglion) peripheral NEC ; Neoplasm, neoplastic nerve (ganglion) peripheral NEC extremity ; etc
Unspecified diagnosis codes like D36.10 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Ancient schwannoma
- Benign neoplasm of autonomic nerve
- Benign neoplasm of peripheral nerve
- Benign tumor of spinal nerve and sheath
- Brachial plexus palsy due to birth trauma
- Cellular schwannoma
- Chronic bilateral vestibulopathy due to bilateral schwannoma
- Cutaneous neuroma
- Dermal nerve sheath myxoma
- Digital pacinian neuroma
- Disorder of nerve repair
- Epithelioid neurofibroma
- Erb Duchenne palsy with neuroma due to birth trauma
- Erb-Duchenne palsy as birth trauma
- Erb-Duchenne paralysis
- Fibrolipomatous hamartoma of nerve
- Glandular schwannoma
- Injury to brachial plexus as birth trauma
- Left vestibulopathy due to neurilemmoma
- Lipoma of nerve
- Lipomatous hamartoma
- Marfanoid physique
- Melanotic schwannoma
- Myxoid neurofibroma
- Neoplasm of autonomic nerve
- Neurofibroma of subcutaneous tissue
- Neuroma of nerve repair
- Pacinian neurofibroma
- Pacinian schwannoma
- Painful orbital and systemic neurofibroma, marfanoid habitus syndrome
- Plexiform neurofibroma
- Plexiform schwannoma
- Reticular perineurioma of peripheral nerve
- Right vestibulopathy due to schwannoma
- Scar neuroma
- Sclerosing perineurioma of peripheral nerve
- Solitary neurofibroma
- Spine injury due to birth trauma
- Tumor of spinal nerve and sheath
- Upper brachial plexus neuropathy
- Ganglioneuroma-. a benign neoplasm that usually arises from the sympathetic trunk in the mediastinum. histologic features include spindle cell proliferation (resembling a neurofibroma) and the presence of large ganglion cells. the tumor may present clinically with horner syndrome or diarrhea due to ectopic production of vasoactive intestinal peptide. (from devita et al., cancer: principles and practice of oncology, 5th ed, p966)
- Genes, Neurofibromatosis 1-. tumor suppressor genes located on the long arm of human chromosome 17 in the region 17q11.2. mutation of these genes is thought to cause neurofibromatosis 1, watson syndrome, and leopard syndrome.
- Genes, Neurofibromatosis 2-. tumor suppressor genes located on the long arm of human chromosome 22. mutation or loss of these genes causes neurofibromatosis 2.
- Neurofibroma-. a moderately firm, benign, encapsulated tumor resulting from proliferation of schwann cells and fibroblasts that includes portions of nerve fibers. the tumors usually develop along peripheral or cranial nerves and are a central feature of neurofibromatosis 1, where they may occur intracranially or involve spinal roots. pathologic features include fusiform enlargement of the involved nerve. microscopic examination reveals a disorganized and loose cellular pattern with elongated nuclei intermixed with fibrous strands. (from adams et al., principles of neurology, 6th ed, p1016)
- Neurofibroma, Plexiform-. a type of neurofibroma manifesting as a diffuse overgrowth of subcutaneous tissue, usually involving the face, scalp, neck, and chest but occasionally occurring in the abdomen or pelvis. the tumors tend to progress, and may extend along nerve roots to eventually involve the spinal roots and spinal cord. this process is almost always a manifestation of neurofibromatosis 1. (from adams et al., principles of neurology, 6th ed, p1016; j pediatr 1997 nov;131(5):678-82)
- Neurofibromatoses-. a group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. neurofibromatosis 1 (generalized neurofibromatosis) accounts for approximately 95% of cases, although multiple additional subtypes (e.g., neurofibromatosis 2, neurofibromatosis 3, etc.) have been described. (from neurochirurgie 1998 nov;44(4):267-72)
- Neurofibromatosis 1-. an autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic neural crest. multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. peripheral and central nervous system neoplasms occur frequently, especially optic nerve glioma and neurofibrosarcoma. nf1 is caused by mutations which inactivate the nf1 gene (genes, neurofibromatosis 1) on chromosome 17q. the incidence of learning disabilities is also elevated in this condition. (from adams et al., principles of neurology, 6th ed, pp1014-18) there is overlap of clinical features with noonan syndrome in a syndrome called neurofibromatosis-noonan syndrome. both the ptpn11 and nf1 gene products are involved in the signal transduction pathway of ras (ras proteins).
- Neurofibromatosis 2-. an autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (neurilemmoma) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. the disease has been linked to mutations of the nf2 gene (genes, neurofibromatosis 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.
- Neurofibromin 1-. a protein found most abundantly in the nervous system. defects or deficiencies in this protein are associated with neurofibromatosis 1, watson syndrome, and leopard syndrome. mutations in the gene (gene, neurofibromatosis 1) affect two known functions: regulation of ras-gtpase and tumor suppression.
- Neurofibromin 2-. a membrane protein homologous to the erm (ezrin-radixin-moesin) family of cytoskeleton-associated proteins which regulate physical properties of membranes. alterations in neurofibromin 2 are the cause of neurofibromatosis 2.
- Cranial Nerve Neoplasms-. benign and malignant neoplasms that arise from one or more of the twelve cranial nerves.
- Morton Neuroma-. a nerve inflammation in the foot caused by chronic compression of the plantar nerve between the metatarsal bones.
- Multiple Endocrine Neoplasia Type 2b-. similar to men2a, it is also caused by mutations of the men2 gene, also known as the ret proto-oncogene. its clinical symptoms include medullary carcinoma (carcinoma, medullary) of thyroid gland and pheochromocytoma of adrenal medulla (50%). unlike men2a, men2b does not involve parathyroid neoplasms. it can be distinguished from men2a by its neural abnormalities such as mucosal neuromas on eyelids; lip; and tongue, and ganglioneuromatosis of gastrointestinal tract leading to megacolon. it is an autosomal dominant inherited disease.
- Neuroma-. a tumor made up of nerve cells and nerve fibers. (dorland, 27th ed)
- Neuroma, Acoustic-. a benign schwannoma of the eighth cranial nerve (vestibulocochlear nerve), mostly arising from the vestibular branch (vestibular nerve) during the fifth or sixth decade of life. clinical manifestations include hearing loss; headache; vertigo; tinnitus; and facial pain. bilateral acoustic neuromas are associated with neurofibromatosis 2. (from adams et al., principles of neurology, 6th ed, p673)
- Horner Syndrome-. a syndrome associated with defective sympathetic innervation to one side of the face, including the eye. clinical features include miosis; mild blepharoptosis; and hemifacial anhidrosis (decreased sweating)(see hypohidrosis). lesions of the brain stem; cervical spinal cord; first thoracic nerve root; apex of the lung; carotid artery; cavernous sinus; and apex of the orbit may cause this condition. (from miller et al., clinical neuro-ophthalmology, 4th ed, pp500-11)
- Metatarsal Bones-. the five long bones of the metatarsus, articulating with the tarsal bones proximally and the phalanges of toes distally.
- Lipomatosis of Nerve|Fibrolipomatous Hamartoma of Peripheral Nerve|Neural Fibrolipoma|Peripheral Nerve Fibrolipomatous Hamartoma-. a tumor composed of mature adipocytes and fibrous tissue infiltrating the epineurium and peripheral nerves. it is often seen at birth or during childhood and may be associated with macrodactyly.
- Lipomatous Hamartoma-. a benign hamartomatous lesion composed predominantly of adipose tissue.
- Thymolipoma|Thymolipomatous Hamartoma-. a well-circumscribed tumor of the thymus composed of islands of normal thymic parenchyma and mature adipose tissue. it is not clear if thymolipoma is a neoplastic or non-neoplastic lesion.
- Epithelioid Neurofibroma-. a rare neurofibroma with epithelioid morphology.
Index to Diseases and Injuries References
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:
- - Gangliocytoma - D36.10
- - Ganglioneuroma - D36.10
- - Ganglioneuromatosis - D36.10
Convert to ICD-9 Code
|Source ICD-10 Code||Target ICD-9 Code|
|D36.10||215.9 - Ben neo soft tissue NOS|
|Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.|
Table of Neoplasms
This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
»ganglia [See Also: Neoplasm, nerve, peripheral]
»autonomic NEC [See Also: Neoplasm, nerve, peripheral]
»ganglion NEC [See Also: Neoplasm, nerve, peripheral]
»sympathetic NEC [See Also: Neoplasm, nerve, peripheral]
»peripheral nerve NEC
»spine, spinal (column)
»spine, spinal (column)
»sympathetic nerve or nervous system NEC
Autonomic Nervous System Disorders
Your autonomic nervous system is the part of your nervous system that controls involuntary actions, such as the beating of your heart and the widening or narrowing of your blood vessels. When something goes wrong in this system, it can cause serious problems, including:
- Blood pressure problems
- Heart problems
- Trouble with breathing and swallowing
- Erectile dysfunction in men
Autonomic nervous system disorders can occur alone or as the result of another disease, such as Parkinson's disease, alcoholism and diabetes. Problems can affect either part of the system, as in complex regional pain syndromes, or all of the system. Some types are temporary, but many worsen over time. When they affect your breathing or heart function, these disorders can be life-threatening.
Some autonomic nervous system disorders get better when an underlying disease is treated. Often, however, there is no cure. In that case, the goal of treatment is to improve symptoms.
NIH: National Institute of Neurological Disorders and Stroke
[Learn More in MedlinePlus]
Tumors are abnormal growths in your body. They can be either benign or malignant. Benign tumors aren't cancer. Malignant ones are. Benign tumors grow only in one place. They cannot spread or invade other parts of your body. Even so, they can be dangerous if they press on vital organs, such as your brain.
Tumors are made up of extra cells. Normally, cells grow and divide to form new cells as your body needs them. When cells grow old, they die, and new cells take their place. Sometimes, this process goes wrong. New cells form when your body does not need them, and old cells do not die when they should. These extra cells can divide without stopping and may form tumor.
Treatment often involves surgery. Benign tumors usually don't grow back.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Peripheral Nerve Disorders
Your peripheral nerves are the ones outside your brain and spinal cord. Like static on a telephone line, peripheral nerve disorders distort or interrupt the messages between the brain and the rest of the body.
There are more than 100 kinds of peripheral nerve disorders. They can affect one nerve or many nerves. Some are the result of other diseases, like diabetic nerve problems. Others, like Guillain-Barre syndrome, happen after a virus infection. Still others are from nerve compression, like carpal tunnel syndrome or thoracic outlet syndrome. In some cases, like complex regional pain syndrome and brachial plexus injuries, the problem begins after an injury. Some people are born with peripheral nerve disorders.
Symptoms often start gradually, and then get worse. They include :
- Burning or tingling
- Muscle weakness
- Sensitivity to touch
Treatment aims to treat any underlying problem, reduce pain and control symptoms.
NIH: National Institute of Neurological Disorders and Stroke
[Learn More in MedlinePlus]
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)